EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment of Mesenchymal Stem Cell-Derived Extracellular Vesicles with Extract of Cultured Lentinula edodes Modulates Breast Cancer Stem Cells and MicroRNA Reprogramming

Farzaneh Sharifzad iD, Nawal Alsadi, Hamed Yasavoli-Sharahi, Roghayeh Shahbazi, Dylan Burger iD, Chantal Matar

Current Issues in Molecular Biology · 01.04.2026 · 48 (4) · 368

DOI: 10.3390/cimb48040368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 01.04.2026. Verfasst von Farzaneh Sharifzad und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nutrition Sciences, Faculty of Health Sciences, University of Ottawa, Ontario, ON K1N 6N5, Canada. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast carcinoma represents the most frequent malignancy in women in Canada, and intrinsic or acquired drug resistance significantly increases the risk of recurrence and metastasis. Although front-line therapy is multimodal, chemoresistance remains a major hurdle in treatment and therapy, and the intake of natural compounds resulting from fermentation processes is currently considered an effective strategy to overcome this problem. This study investigated the effect of extracellular vesicles (EVs) from Mesenchymal Stromal/stem cells (MSCs) pretreated with cultured Lentinula edodes extract (AHCC) on reducing chemoresistance and modulating microRNAs in the MCF-7 and MCF-7/DOX cell lines. EV characterization was performed using nanoparticle tracking analysis, and microRNAs and the formation of cancer stem cells were studied. The miRNA analysis revealed that AHCC significantly downregulated oncogenic miR-155 but upregulated the tumor-suppressive microRNAs miR-34a, miR-Let7a, and miR-200c. In vitro experiments showed inhibition of cancer stem cell proliferation after challenging the cells with AHCC-pretreated EVs. Conclusion: Our data demonstrated that AHCC may contribute to modulation of the tumor microenvironment, thus influencing the development of cancer stem cells.

Schlagwörter

Stichwörter der Autor:innen

Lentinula edodescancer stem cellsextracellular vesiclemesenchymal stem cellmicroRNAs

Autor:innen und Institutionen

  • School of Nutrition Sciences, Faculty of Health Sciences, University of Ottawa, Ontario, ON K1N 6N5, Canada.
  • Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ontario, ON K1N 6N5, Canada.
  • Kidney Research Centre, The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

ORCID-Profile: Farzaneh Sharifzad, Dylan Burger

Zitieren

APA

Sharifzad, F., Alsadi, N., Yasavoli-Sharahi, H., Shahbazi, R., Burger, D., & Matar, C. (2026). Treatment of Mesenchymal Stem Cell-Derived Extracellular Vesicles with Extract of Cultured Lentinula edodes Modulates Breast Cancer Stem Cells and MicroRNA Reprogramming. Current Issues in Molecular Biology, 48(4), 368. https://doi.org/10.3390/cimb48040368

Vancouver

Sharifzad F, Alsadi N, Yasavoli-Sharahi H, Shahbazi R, Burger D, Matar C. Treatment of Mesenchymal Stem Cell-Derived Extracellular Vesicles with Extract of Cultured Lentinula edodes Modulates Breast Cancer Stem Cells and MicroRNA Reprogramming. Current Issues in Molecular Biology. 2026;48(4):368. doi:10.3390/cimb48040368

BibTeX
@article{Sharifzad2026,
  author = {Sharifzad, Farzaneh and Alsadi, Nawal and Yasavoli-Sharahi, Hamed and Shahbazi, Roghayeh and Burger, Dylan and Matar, Chantal},
  title = {Treatment of Mesenchymal Stem Cell-Derived Extracellular Vesicles with Extract of Cultured Lentinula edodes Modulates Breast Cancer Stem Cells and MicroRNA Reprogramming},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {368},
  doi = {10.3390/cimb48040368}
}
Kostenlos starten →